Literature DB >> 15197476

Differential distribution of TASK-1, TASK-2 and TASK-3 immunoreactivities in the rat and human cerebellum.

Z Rusznák1, K Pocsai, I Kovács, A Pór, B Pál, T Bíró, G Szücs.   

Abstract

In this work, the distributions of some acid-sensitive two-pore-domain K+ channels (TASK-1, TASK-2 and TASK-3) were investigated in the rat and human cerebellum. Astrocytes situated in rat cerebellar tissue sections were positive for TASK-2 channels. Purkinje cells were strongly stained and granule cells and astrocytes were moderately positive for TASK-3. Astrocytes isolated from the hippocampus, cerebellum and cochlear nucleus expressed TASK channels in a primary tissue culture. Our results suggest that TASK channel expression may be significant in the endoplasmic reticulum of the astrocytes. The human cerebellum showed weak TASK-2 immunolabelling. The pia mater, astrocytes, Purkinje and granule cells demonstrated strong TASK-1 and TASK-3 positivities. The TASK-3 labelling was stronger in general, but it was particularly intense in the Purkinje cells and pia mater.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197476     DOI: 10.1007/s00018-004-4082-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  16 in total

1.  Deafness associated changes in expression of two-pore domain potassium channels in the rat cochlear nucleus.

Authors:  Avril Genene Holt; Mikiya Asako; R Keith Duncan; Catherine A Lomax; Jose M Juiz; Richard A Altschuler
Journal:  Hear Res       Date:  2006-05-02       Impact factor: 3.208

2.  Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells.

Authors:  Zoltán Rusznák; Gábor Bakondi; Lívia Kosztka; Krisztina Pocsai; Beatrix Dienes; János Fodor; Andrea Telek; Mónika Gönczi; Géza Szucs; László Csernoch
Journal:  Virchows Arch       Date:  2007-12-20       Impact factor: 4.064

3.  Immunocytochemical localization of TASK-3 protein (K2P9.1) in the rat brain.

Authors:  Christiane Marinc; Christian Derst; Harald Prüss; Rüdiger W Veh
Journal:  Cell Mol Neurobiol       Date:  2014-01       Impact factor: 5.046

4.  TASK-3: New Target for Pain-Relief.

Authors:  Wen-Jing Ren; Henning Ulrich; Alexey Semyanov; Peter Illes; Yong Tang
Journal:  Neurosci Bull       Date:  2020-05-26       Impact factor: 5.203

5.  The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.

Authors:  Claudia P Alvarez-Baron; Philip Jonsson; Christoforos Thomas; Stuart E Dryer; Cecilia Williams
Journal:  Mol Endocrinol       Date:  2011-06-16

6.  TASK-3 immunoreactivity shows differential distribution in the human gastrointestinal tract.

Authors:  Ilona Kovács; Krisztina Pocsai; Gabriella Czifra; László Sarkadi; Géza Szucs; Zoltán Nemes; Zoltán Rusznák
Journal:  Virchows Arch       Date:  2005-03-24       Impact factor: 4.064

7.  Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9.

Authors:  Ortal Barel; Stavit A Shalev; Rivka Ofir; Asi Cohen; Joel Zlotogora; Zamir Shorer; Galia Mazor; Gal Finer; Shareef Khateeb; Noam Zilberberg; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

8.  Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

Authors:  D M Wilcock; M P Vitek; C A Colton
Journal:  Neuroscience       Date:  2009-01-19       Impact factor: 3.590

9.  Deafness associated changes in two-pore domain potassium channels in the rat inferior colliculus.

Authors:  Y L Cui; A G Holt; C A Lomax; R A Altschuler
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

10.  Acid-sensitive channel inhibition prevents fetal alcohol spectrum disorders cerebellar Purkinje cell loss.

Authors:  Jayanth Ramadoss; Emilie R Lunde; Nengtai Ouyang; Wei-Jung A Chen; Timothy A Cudd
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-28       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.